產(chǎn)品詳情
  • 產(chǎn)品名稱:EF-handcalciumbindingdomain14(EFCAB14)(C-Term)Peptide

  • 產(chǎn)品型號:
  • 產(chǎn)品廠商:半導(dǎo)體
  • 產(chǎn)品文檔:
你添加了1件商品 查看購物車
簡單介紹:
EF-handcalciumbindingdomain14(EFCAB14)(C-Term)Peptide
詳情介紹:
Blocked Antibody anti-SUMO3 antibody (SMT3 Suppressor of Mif Two 3 Homolog 3 (S. Cerevisiae)) (N-Term) (ABIN2782380)
Sequence PKEGVKTEND HINLKVAGQD GSVVQFKIKR HTPLSKLMKA YCERQGLSMR
Characteristics This is a synthetic peptide designed for use in combination with anti-Sumo3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Purification Purified
Background Sumo3 is a ubiquitin-like protein which can be covalently attached to target lysines either as a monomer or as a lysine-linked polymer. It does not seem to be involved in protein degradation and may function as an antagonist of ubiquitin in the degradation process. It plays a role in a number of cellular processes such as nuclear transport, DNA replication and repair, mitosis and signal transduction. Covalent attachment to its substrates requires prior activation by the E1 complex SAE1-SAE2 and linkage to the E2 enzyme UBE2I, and can be promoted by an E3 ligase such as PIAS1-4, RANBP2 or CBX4.

Alias Symbols: 2810014B19Rik, AA409334, AW121497, AW536077, D10Ertd345e, SMT3A, SUMO-3, Smt3h1, Smt3B

Protein Size: 110
Molecular Weight 12 kDa
Gene ID 20610
NCBI Accession NM_019929, NP_064313
UniProt Q9Z172
Application Notes Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions For Research Use only
Format Lyophilized
Reconstitution Add 100?μL of sterile PBS. Final peptide concentration is 1?mg/mL in PBS.
Concentration 1 mg/mL
Buffer Final peptide concentration is 1 mg/mL in PBS.
Handling Advice Avoid repeated freeze-thaw cycles.
Storage -20 °C
Storage Comment For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.